{
  "id": 4775,
  "url": "https://nnemf.org/research/4775-1950-mhz-electromagnetic-fields-ameliorate-a-pathology-in",
  "title": "1950 MHz Electromagnetic Fields Ameliorate Aβ Pathology in Alzheimer's Disease Mice.",
  "authors": [
    "Ye Ji Jeong",
    "Ga-Young Kang",
    "Jong Hwa Kwon",
    "Hyung-Do Choi",
    "Jeong-Ki Pack",
    "Nam Kim",
    "Yun-Sil Lee",
    "Hae-June Lee"
  ],
  "journal": "Current Alzheimer research",
  "year": "2015",
  "doi": "10.2174/156720501205150526114448",
  "pmid": "26017559",
  "abstract": "The involvement of radiofrequency electromagnetic fields (RF-EMF) in the neurodegenerative disease, especially Alzheimer's disease (AD), has received wide consideration, however, outcomes from several researches have not shown consistency. In this study, we determined whether RF-EMF influenced AD pathology in vivo using Tg-5xFAD mice as a model of AD-like amyloid β (Aβ) pathology. The transgenic (Tg)-5xFAD and wild type (WT) mice were chronically exposed to RF-EMF for 8 months (1950 MHz, SAR 5W/kg, 2 hrs/day, 5 days/week). Notably, chronic RFEMF exposure significantly reduced not only Aβ plaques, APP, and APP carboxyl-terminal fragments (CTFs) in whole brain including hippocampus and entorhinal cortex but also the ratio of Aβ42 and Aβ40 peptide in the hippocampus of Tg-5xFAD mice. We also found that parenchymal expression of β-amyloid precursor protein cleaving enzyme 1(BACE1) and neuroinflammation were inhibited by RF-EMF exposure in Tg-5xFAD. In addition, RF-EMF was shown to rescue memory impairment in Tg-5xFAD. Moreover, gene profiling from microarray data using hippocampus of WT and Tg- 5xFAD following RF-EMF exposure revealed that 5 genes (Tshz2, Gm12695, St3gal1, Isx and Tll1), which are involved in Aβ, are significantly altered inTg-5xFAD mice, exhibiting different responses to RF-EMF in WT or Tg-5xFAD mice; RF-EMF exposure in WT mice showed similar patterns to control Tg-5xFAD mice, however, RF-EMF exposure in Tg- 5xFAD mice showed opposite expression patterns. These findings indicate that chronic RF-EMF exposure directly affects Aβ pathology in AD but not in normal brain. Therefore, RF-EMF has preventive effects against AD-like pathology in advanced AD mice with a high expression of Aβ, which suggests that RF-EMF can have a beneficial influence on AD.",
  "effect": "benefit",
  "evidence": "low",
  "extraction": {
    "studyType": "animal",
    "studyTypeLabel": "Animal study",
    "effectDirection": "benefit",
    "evidenceLabel": "Low",
    "population": "Tg-5xFAD transgenic mice (Alzheimer’s disease model) and wild type mice",
    "sampleSize": "—",
    "exposure": "RF · 1950 MHz · 5 W/kg · 8 months; 2 hrs/day, 5 days/week",
    "confidencePct": "78",
    "peerReviewed": "yes",
    "mainFindings": "Tg-5xFAD and wild type mice were chronically exposed to 1950 MHz RF-EMF (SAR 5 W/kg) for 8 months. In Tg-5xFAD mice, exposure significantly reduced Aβ plaques, APP and APP-CTFs in whole brain (including hippocampus and entorhinal cortex), reduced the hippocampal Aβ42/Aβ40 ratio, inhibited BACE1 expression and neuroinflammation, and rescued memory impairment. Gene profiling indicated five Aβ-related genes were significantly altered in Tg-5xFAD mice with different response patterns in WT versus Tg-5xFAD following exposure.",
    "outcomes": [
      "Aβ plaques",
      "APP and APP carboxyl-terminal fragments (CTFs)",
      "Hippocampal Aβ42/Aβ40 ratio",
      "BACE1 expression",
      "Neuroinflammation",
      "Memory impairment/behavior",
      "Hippocampal gene expression (microarray",
      "Tshz2",
      "Gm12695",
      "St3gal1",
      "Isx",
      "Tll1)"
    ],
    "limitations": [
      "Sample size not reported in abstract",
      "Exposure source/setup (e.g.",
      "device/field characteristics beyond frequency and SAR) not described in abstract",
      "Findings are from an animal model",
      "relevance to humans not addressed in abstract"
    ],
    "keywords": [
      "radiofrequency electromagnetic fields",
      "RF-EMF",
      "1950 MHz",
      "SAR 5 W/kg",
      "Alzheimer's disease",
      "Tg-5xFAD",
      "amyloid beta",
      "Aβ plaques",
      "APP",
      "BACE1",
      "neuroinflammation",
      "memory",
      "microarray"
    ],
    "hubs": [],
    "raw": "{\n  \"study_type\": \"animal\",\n  \"exposure\": {\n    \"band\": \"RF\",\n    \"source\": null,\n    \"frequency_mhz\": 1950,\n    \"sar_wkg\": 5,\n    \"duration\": \"8 months; 2 hrs/day, 5 days/week\"\n  },\n  \"population\": \"Tg-5xFAD transgenic mice (Alzheimer’s disease model) and wild type mice\",\n  \"sample_size\": null,\n  \"outcomes\": [\n    \"Aβ plaques\",\n    \"APP and APP carboxyl-terminal fragments (CTFs)\",\n    \"Hippocampal Aβ42/Aβ40 ratio\",\n    \"BACE1 expression\",\n    \"Neuroinflammation\",\n    \"Memory impairment/behavior\",\n    \"Hippocampal gene expression (microarray; Tshz2, Gm12695, St3gal1, Isx, Tll1)\"\n  ],\n  \"main_findings\": \"Tg-5xFAD and wild type mice were chronically exposed to 1950 MHz RF-EMF (SAR 5 W/kg) for 8 months. In Tg-5xFAD mice, exposure significantly reduced Aβ plaques, APP and APP-CTFs in whole brain (including hippocampus and entorhinal cortex), reduced the hippocampal Aβ42/Aβ40 ratio, inhibited BACE1 expression and neuroinflammation, and rescued memory impairment. Gene profiling indicated five Aβ-related genes were significantly altered in Tg-5xFAD mice with different response patterns in WT versus Tg-5xFAD following exposure.\",\n  \"effect_direction\": \"benefit\",\n  \"limitations\": [\n    \"Sample size not reported in abstract\",\n    \"Exposure source/setup (e.g., device/field characteristics beyond frequency and SAR) not described in abstract\",\n    \"Findings are from an animal model; relevance to humans not addressed in abstract\"\n  ],\n  \"evidence_strength\": \"low\",\n  \"confidence\": 0.78,\n  \"peer_reviewed_likely\": \"yes\",\n  \"keywords\": [\n    \"radiofrequency electromagnetic fields\",\n    \"RF-EMF\",\n    \"1950 MHz\",\n    \"SAR 5 W/kg\",\n    \"Alzheimer's disease\",\n    \"Tg-5xFAD\",\n    \"amyloid beta\",\n    \"Aβ plaques\",\n    \"APP\",\n    \"BACE1\",\n    \"neuroinflammation\",\n    \"memory\",\n    \"microarray\"\n  ],\n  \"suggested_hubs\": []\n}"
  },
  "synthesis": null,
  "synthesisStatus": "pending",
  "originalHref": "https://pubmed.ncbi.nlm.nih.gov/26017559/",
  "sourceUrl": "https://rfsafe.org/mel/paper.php?id=4775",
  "updated": "2026-02-14 08:04:35"
}